---
title: "诺和诺德基金会主席索伦森：我认为新董事会中至少有部分成员拥有经营制药公司的更直接的运营经验。"
description: "诺和诺德基金会主席索伦森：我认为新董事会中至少有部分成员拥有经营制药公司的更直接的运营经验。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262081227.md"
published_at: "2025-10-21T13:55:31.000Z"
---

# 诺和诺德基金会主席索伦森：我认为新董事会中至少有部分成员拥有经营制药公司的更直接的运营经验。

诺和诺德基金会主席索伦森：我认为新董事会中至少有部分成员拥有经营制药公司的更直接的运营经验。

### Related Stocks

- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk Proposes Two Additional New Board Appointments | Danish pharmaceutical company Novo Nordisk is proposing three new appointments to its board of directors for the annual  | [Link](https://longbridge.com/zh-CN/news/276442777.md) |
| Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | [Link](https://longbridge.com/zh-CN/news/276440991.md) |
| Puzo Michael J Has $320,000 Stock Position in Novo Nordisk A/S $NVO | Puzo Michael J significantly reduced its stake in Novo Nordisk A/S (NYSE:NVO) by 86.9% in Q3, now holding 5,775 shares v | [Link](https://longbridge.com/zh-CN/news/276447697.md) |
| Novo Nordisk: Will Have Replacements for Ozempic and Wegovy Ready When Patents Expire - Berlingske | Danish pharmaceutical company Novo Nordisk plans to have replacement drugs ready for Ozempic and Wegovy when their paten | [Link](https://longbridge.com/zh-CN/news/276314777.md) |
| Novo Nordisk A/S - share repurchase programme | Novo Nordisk A/S has initiated a share repurchase programme of up to DKK 15 billion, starting from 4 February 2026. As o | [Link](https://longbridge.com/zh-CN/news/276056741.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
